HCP (HCP) Set to Announce Quarterly Earnings on Wednesday

HCP (NYSE:HCP) will post its quarterly earnings results after the market closes on Wednesday, October 30th. Analysts expect HCP to post earnings of $0.43 per share for the quarter. HCP has set its FY19 guidance at $1.73-1.77 EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

HCP (NYSE:HCP) last released its quarterly earnings results on Wednesday, July 31st. The real estate investment trust reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.46). The firm had revenue of $489.15 million for the quarter, compared to analyst estimates of $444.67 million. HCP had a net margin of 53.57% and a return on equity of 15.54%. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.45 EPS. On average, analysts expect HCP to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

HCP stock opened at $37.52 on Wednesday. The firm has a market cap of $18.36 billion, a PE ratio of 20.62, a P/E/G ratio of 6.96 and a beta of 0.23. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.90 and a current ratio of 0.90. The firm’s fifty day moving average is $35.74 and its 200 day moving average is $32.93. HCP has a one year low of $25.82 and a one year high of $37.87.

Several analysts recently commented on the stock. ValuEngine lowered shares of HCP from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. TheStreet upgraded shares of HCP from a “c+” rating to a “b-” rating in a research report on Friday, August 2nd. Stifel Nicolaus raised their price target on shares of HCP from $34.00 to $37.00 and gave the company a “buy” rating in a research report on Tuesday, September 3rd. They noted that the move was a valuation call. KeyCorp raised their price target on shares of HCP from $34.00 to $37.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Zacks Investment Research upgraded shares of HCP from a “hold” rating to a “buy” rating and set a $39.00 price target on the stock in a research report on Monday, October 14th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $36.10.

In other HCP news, COO Thomas Klaritch sold 35,014 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total transaction of $1,261,204.28. Following the transaction, the chief operating officer now directly owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.13% of the company’s stock.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Read More: Insider Trading

Earnings History for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit